Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor κB

Cancer Research

Volumn 60, Issue 23, 2000, Pages 6557-6562

  Andela, V B ^a   Schwarz, E M ^a   Puzas, J E ^a   O'Keefe, R J ^a   Rosier, R N ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; HEPARANASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 2; RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CHICKEN; DOWN REGULATION; ELECTROPHORETIC MOBILITY; EMBRYO; IMMUNOHISTOCHEMISTRY; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ALLANTOIS; ANIMALS; CELL DIVISION; CHICK EMBRYO; CHORION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCURONIDASE; HUMANS; I-KAPPA B PROTEINS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; NF-KAPPA B; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSFECTION; UP-REGULATION; URINARY PLASMINOGEN ACTIVATOR;

EID: 0034541196     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Pro-inflammatory signaling: Last pieces in the NF-κB puzzle?
2. Innovative treatment programs against cancer: II. Nuclear factor-κB (NF-κB) as a molecular target
3. Rel/NF-κ B/I κ B family: Intimate tales of association and dissociation
4. Defining therapeutic targets by using adenovirus: Blocking NF-κB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators
5. Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases
6. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer
7. Stable inhibition of nuclear factor κB in cancer cells does not increase sensitivity to cytotoxic drugs
8. Control of tumor development by intratumoral cytokines
9. Modulation of the immune response and tumor growth by activated Ras
10. Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB
11. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay
12. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: An absolute requirement for transcription factor NF-κ B
13. Negative regulation of transactivation function but not DNA binding of NF-κB and AP-1 by IκBβ1 in breast cancer cells
14. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis
15. Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis
16. Major co-localization of the extracellular-matrix degradative enzymes heparanase and gelatinase in tertiary granules of human neutrophils
17. Suppression of TNF-α-induced apoptosis by NF-κB
18. NFkB mediated inhibition of apoptosis is required for encephalomyocarditis virus virulence: A mechanism of resistance in p50 knockout mice
19. Tritiated thymidine and bromodeoxyuridine double-labelling studies on growth factors and oral epithelial proliferation in the mouse
20. Activation of proMMP-9 by a plasmin/MMP-3 cascade in a tumor cell model. Regulation by tissue inhibitors of metalloproteinases
21. Plasminogen activator inhibitor type 2 in breast cancer
22. Matrix metalloproteinases and metastasis
23. Glycosidases in cancer and invasion
24. Structure, regulation and function of NFκB
25. The host environment promotes the constitutive activation of nuclear factor-κB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma